Prolonged hemodialysis for acute kidney injury in myeloma patients

Clinical Nephrology

Volumn 74, Issue 4, 2010, Pages 319-322

  Hanf, W ^a   Guillaume, C ^a   Jolivot, A ^a   Chapuis Cellier, C ^a   Guebre Egziabher, F ^a   Fontana, A ^a   Fouque, D ^a   Juillard, L ^a,b  

^a EDOUARD HERRIOT HOSPITAL   (France)

^b UNIVERSITÉ DE LYON   (France)

Author keywords

Hemodialysis; Kidney injury; Light chains; Multiple myeloma

Indexed keywords

BORTEZOMIB; CITRIC ACID; DEXAMETHASONE; IMMUNOGLOBULIN D; IMMUNOGLOBULIN G; LENALIDOMIDE; POLYSULFONE; THALIDOMIDE;

AGED; ARTICLE; CASE REPORT; DEVICE; FEMALE; HEMODIALYSIS; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; KIDNEY INJURY; MAINTENANCE THERAPY; MALE; MULTIPLE CYCLE TREATMENT; MULTIPLE MYELOMA; TREATMENT DURATION;

EID: 77957677943     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/cnp74319     Document Type: Article

References (13)

1. Singhal S, Mehta J. Multiple myeloma. Clin J Am Soc Nephrol. 2006; 1: 1322-1330.
2. Dimopoulos MA, Kastritis E, Rosinol L, Blade J, Ludwig H. Pathogenesis and treatment of renal failure in multiple myeloma. Leukemia. 2008; 22: 1485-1493.
3. Blade J, Fernandez-Llama P, Bosch F, Montolíu J, Lens XM, Montoto S, Cases A, Darnell A, Rozman C, Montserrat E. Renal failure inmultiplemyeloma: presenting features and predictors of outcome in 94 patients froma single institution. Archives of internal medicine. 1998; 158: 1889-1893. (Pubitemid 28440861)
4. Hutchison CA, Cockwell P, Reid S, Chandler K, Mead GP, Harrison J, Hattersley J, Evans ND, Chappell MJ, Cook M, Goehl H, Storr M, Bradwell AR. Efficient removal of immunoglobulin free light chains by hemodialysis for multiple myeloma: in vitro and in vivo studies. J AmSoc Nephrol. 2007; 18: 886-895.
5. Hofbauer R, Moser D, Frass M, Oberbauer R, Kaye AD, Wagner O, Kapiotis , Druml W. Effect of anticoagulation on blood membrane interactions during hemodialysis. Kid Int. 1999; 56: 1578-1583.
6. Clark WF, Garg AX. Plasma exchange for myeloma kidney: cast(s)away?Kid Int. 2008; 73: 1211-1213.
7. Clark WF, Stewart AK, Rock GA, Sternbach M, Sutton DM, Barrett BJ, Heidenheim AP, Garg AX, Churchill DN. Canadian Apheresis Group Plasma exchange when myeloma presents as acute renal failure: a randomized, controlled trial. Annals of internal medicine. 2005; 143: 777-784.
8. Clark WF. Correction: Plasma exchange when myeloma presents as acute renal failure. Annals of internal medicine. 2007; 146: 471. (Pubitemid 351650589)
9. Leung N, Gertz MA, Zeldenrust SR, Rajkumar SV, Dispenzieri A, Fervenza FC, Kumar S, Lacy MQ, Lust JA, Greipp PR, Witzig TE, Hayman SR, Russell SJ, Kyle RA, Winters JL. Improvement of cast nephropathy with plasma exchange depends on the diagnosis and on reduction of serum free light chains. Kid Int. 2008; 73: 1282-1288. (Pubitemid 351693147)
10. Ludwig H, Drach J, Graf H, Lang A, Meran JG. Reversal of acute renal failure by bortezomib-based chemotherapy in patients with multiple myeloma. Haematologica. 2007; 92: 1411-1414. (Pubitemid 350144160)
11. Weber DM, Chen C, Niesvizky R, Wang M, Belch A, Stadtmauer EA, Siegel D, Borrello I, Rajkumar SV, Chanan-Khan AA, Lonial S, Yu Z, Patin J, Olesnyckyj M, Zeldis JB, Knight RD. Multiple Myeloma (009) Study Investigators Lenalidomide plus dexamethasone for relapsed multiple myeloma in North America. N Engl J Med. 2007; 357: 2133-2142. (Pubitemid 350146108)
12. Hutchison CA, Cook M, Heyne N, Weisel K, Billingham L, Bradwell A, Cockwell P. European trial of free light chain removal by extended haemodialysis in cast nephropathy (EuLITE): A randomised control trial. Trials. 2008; 9: 55.
13. Hutchison CA, Harding S, Mead G, Goehl H, Storr M, Bradwell A, Cockwell P. Serum free-light chain removal by high cutoff hemodialysis: optimizing removal and supportive care. Artificial organs. 2008; 32: 910-917.